TGA expectations for overseas manufacturing sites hosting remote inspections during the COVID-19 pandemic
Information to assist overseas manufactures who may undergo a remote Good Manufacturing Practice (GMP) inspection during the COVID-19 pandemic.
Published
Related content
-
GMP surveillance inspections and extended validity of TGA GMP certificates
Information for manufacturers and sponsors regarding a new method for GMP inspections that will be used from 1 July 2024 and the extended validity of TGA issued GMP Certificates. -
TGA response to coronavirus (COVID-19)
Information updated following the cessation of the Therapeutic Goods (Medical Devices—Accredited Pathology Laboratories) (COVID-19 Emergency) Exemption 2020 -
New regulatory arrangements support businesses and health professionals to communicate and incentivise COVID-19 vaccination
The TGA has implemented arrangements to facilitate the communication of information about approved COVID-19 vaccines.